Published  • loading... • Updated 
First clinical trial of pig kidney transplants gets underway
The trial aims to address the shortage of over 100,000 kidney patients on the U.S. transplant list by testing gene-edited pig kidneys for improved human compatibility.
- The first clinical trial of pig kidney transplants has begun, announced by United Therapeutics, with a successful initial transplant performed at NYU Langone Health.
 - This trial is the first of its kind globally for xenotransplantation and will start with six participants, with potential expansion if successful.
 - The Food and Drug Administration is supporting these studies after previous mixed results from compassionate use experiments.
 - NYU's Dr. Robert Montgomery stated, "This thing is moving in the right direction" based on patient experiences in the trial.
 
Insights by Ground AI
35 Articles
35 Articles
United Therapeutics, a producer of genetically modified pig kidneys, announced Monday that the first transplant in the clinical trial was successfully performed at NYU Langone Health.
Reposted by 
The Independent (US)
Groundbreaking pig organ transplant trial gets underway
It’s the latest step in the quest for animal-to-human transplants
·London, United Kingdom
Read Full ArticleFirst Clinical Trial of Pig Kidney Transplants Gets Underway
·New York, United States
Read Full ArticleUnited Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - Life Sciences British Columbia
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.- United Therapeutics Corporation announced the first clinical xenotransplantation in […]
Coverage Details
Total News Sources35
Leaning Left8Leaning Right2Center22Last UpdatedBias Distribution69%  Center
Bias Distribution
- 69% of the sources are Center
 
69% Center
L 25%
C 69%
Factuality
To view factuality data please Upgrade to Premium















